Navigation Links
Parkinson's Targets Two Distinct Brain Networks, Finds Study

A new research has found that Parkinson's disease targets two distinct brain networks in humans .

The study, carried out by David Eidelberg, MD, head of the Center for Neurosciences at The Feinstein Institute for Medical Research, and his colleagues, found that Parkinson's attacks another brain network that regulates cognitive thought and the ability to perform everyday tasks.

Eidelberg and his team measured and quantified this network of brain regions during a five-year study of newly diagnosed Parkinson's patients who agreed to be followed several times over the course of the study.

This is the first longitudinal study of Parkinson's disease using a brain scan to follow these Parkinson's network over time. The new report appears in an online version in the journal Brain, and will be published soon in a print version.

Dr. Eidelberg said that the new precise technology, to diagnose the two brain networks, could be used to measure the degenerative disease process and the person's response to treatments.

The study also shows that the standard drugs used to treat Parkinson's modify the areas that are involved in movement but not those that regulate cognition. The network that grows abnormal over time includes an called the pre-frontal cortex, known as the brain's executive secretary; organizing, planning and carrying out tasks in order of importance. It's the same region that is hard-hit in mild cognitive impairment, the precursor to Alzheimer's dementia. But Eidelberg said that the symptoms in the two diseases are quite different. But thinking that medicines used for Alzheimer's might help normalize this network, the scientists gave Parkinson's patients eight weeks of treatment, but it didn't work.

"We really don't know precisely what's going on in this newly-identified network, but we can begin to ask questions and figure it out. We don't even know whether this network can be fixed," said Dr. Eidelberg.

In 1999, the researchers recruited 15 patients with early stage Parkinson's and signed them on to get brain scans at different points all through the study. Some were on medicines and some were not. The first networks to be identified were the basal ganglia, thalamus and brain stem that regulate movement. The scans they used measured glucose metabolism - the brain's fuel - and identified areas in this motor network that showed decreased metabolic activity and some areas that had increased metabolic activity. Over time, the cognitive network became apparent. And as the disease progressed and symptoms worsened, this network also took its toll.

"The circuits are like a fingerprint of the disease. As the disease gets worse, the fingerprint is much easier to identify. The cognitive problems are real and have to be addressed. The medicines for Parkinson's don't seem to do anything to alter these networks and we need new ones to target these symptoms," Dr. Eidelberg said.

Eidelberg added that the networks could be used as biomarkers to diagnose the disease. The scientists have also developed mathematical computer models to determine how fast the disease will progress.

"These scanning techniques may be helpful in determining what treatments work and what don't," he said.


'"/>




Related medicine news :

1. Evidence Links Protein Damage to Neurodegenerative diseases like Parkinsons and Alzheimers
2. Link between Constipation and Parkinsons Disease
3. Alternative therapies popular with Parkinsons patients
4. Poisonous Parkinsons molecule discovered
5. Cell transplants used to fend off Parkinsons symptoms
6. Coenzyme Q10 may reduce risk of Parkinsons disease
7. Vitamin E rich diet guards from Parkinsons
8. New hope for patients with Parkinsons disease
9. Parkinsons disease as a result of Head injuries
10. Homocysteine The Cause Of Depression In Patients With Parkinsons
11. Stopping The Progression Of Parkinsons Disease
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/7/2016)... ... December 07, 2016 , ... Castle Dermatology Institute is now offering liquid ... a more youthful appearance to the face. Dr. Peyman Ghasri and Dr. Pedram Ghasri, ... of other treatments, to rejuvenate and renew the facial appearance. , Sculptra is ...
(Date:12/7/2016)... , ... December 07, 2016 , ... They are musicians ... sisters and wives, brothers and fathers, from New England and around the nation. What ... stigma, and are brought together in a beautiful and compelling new photographic exhibit debuting ...
(Date:12/7/2016)... ... December 07, 2016 , ... The Cliff Hart ... in South Lyon, Dewitt, Williamston, East Lansing, Ann Arbor, and Farmington Hills, is ... for a brain tumor. , Jason Bauer and his family are longtime members ...
(Date:12/7/2016)... ... ... One of two inventors from Glen Burnie, Md., has a granddaughter who uses ... why the co-inventor and I have designed a new and better way to secure ... the patent-pending AV-AIR, a device that serves as an alternative to conventional methods of ...
(Date:12/7/2016)... ... OCTOBER XX, 2016 (PRWEB) (PRWEB) December 07, 2016 , ... ... entitled “Canine Filamentous Dermatitis Associated with Borrelia Infection” reveals that ... was published in the prestigious Journal of Veterinary Science & Medical Diagnosis. , ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... -- Global Cervical Dysplasia Market: Scope and Methodology ... market analyzes the current and future prospects of ... summary, including a market snapshot that provides overall ... research is a combination of primary and secondary ... research efforts along with information collected from telephonic ...
(Date:12/7/2016)... 2016  Palatin Technologies, Inc. ("Palatin") (NYSE MKT: ... previously disclosed underwritten public offering of units with ... sole book-running manager, Roth Capital Partners acted as ... co-manager for the offering. "This financing ... proceeds, allowing us to continue advancing bremelanotide for ...
(Date:12/7/2016)... NEW YORK , Dec. 7, 2016 /PRNewswire/ ... This report on pulmonary drugs studies the current ... globally. The stakeholders of this report include companies ... of various pulmonary/respiratory drugs and/or drug-device combinations as ... market. This report comprises an elaborate executive summary ...
Breaking Medicine Technology: